Cantex Pharmaceuticals
Weston, Florida, United States
About Cantex Pharmaceuticals
Cantex Pharmaceuticals is a biotechnology company engaged in harnessing known therapies to develop novel and safer cancer treatments. Cantex is currently conducting two unique development programs with modified versions of two separate known chemical entities each of which addresses major unmet medical needs representing high-value market opportunities:
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $33.6M
- Funding stage: Late Stage Venture
- Last round: Debt Financing (Apr 2014)
- Website: cantex.com
- Phone: 954-315-3660
Industries & Categories
Biopharma, Biotechnology, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cantex-pharmaceuticals-2514269 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.